Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
All Genders
NCT06960564

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

Led by Istanbul University · Updated on 2026-01-09

50

Participants Needed

1

Research Sites

45 weeks

Total Duration

On this page

Sponsors

I

Istanbul University

Lead Sponsor

I

Istanbul University Research Fund

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this study, the effect of intra-articular HA injection therapy on pre- and post-treatment TNF-alpha and IL-1beta levels and methylation changes in blood and synovial fluid in patients with knee osteoarthritis will be determined and compared with the placebo group. In addition, the effects of HA injection on pain, functional status and quality of life will be evaluated and these effects will be related to changes in TNF-alpha and IL-1-beta.

CONDITIONS

Official Title

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

Who Can Participate

Age: 45Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of knee osteoarthritis according to American College of Rheumatology criteria
  • Knee pain for more than 3 months
  • Knee pain resistant to conservative treatment for at least 3 months
  • Age between 45 and 75 years
  • Kellgren-Lawrence stage 2-3 gonarthrosis on knee X-rays
Not Eligible

You will not qualify if you...

  • Kellgren-Lawrence stage 1 or 4 osteoarthritis
  • Severe cardiovascular disease, renal failure, hepatic failure, uncontrolled diabetes, cancer, immunosuppression, haematological or systemic bone diseases
  • Bleeding tendency (INR >2 in patients on Coumadin)
  • Systemic or local infection
  • Secondary knee osteoarthritis (inflammatory, post-traumatic, post-infectious, etc.)
  • Major knee trauma within the last year
  • Body mass index over 40
  • History of total knee or hip replacement within 1 year
  • Pregnancy
  • Intra-articular injection within the last 6 months
  • Hemoglobin less than 11 g/dl or platelet count less than 150,000
  • Allergy to hyaluronic acid products

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istanbul University, Istanbul Faculty of Medicine

Istanbul, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

D

Dicle Rotinda Özdaş Sevgin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here